Medical College of Wisconsin

Froedtert Hospital

Milwaukee, WI
Website
(831) 888-0898Refer Patient

Accepting patients

Genomically-Guided Treatment Trial in Brain Metastases
Learn more
  • PI3K Inhibitor
  • Tyrosine Kinase (TK) Inhibitor
  • CDK6
  • Phase 2

Accepting patients

VMD-928

An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma
Learn more
  • Tyrosine Kinase (TK) Inhibitor
  • Phase 1
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

Accepting patients

Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Learn more
  • Pan-RAF Kinase Inhibitor
  • Phase 2